The study suggests that tesofensine, particularly at a dose of 0.5 mg, has the potential to produce twice the weight loss compared to currently approved drugs for obesity
Each lot of Semaglutide is independently tested
Drucker, who is an endocrinologist, Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology and professor of medicine in the division of endocrinology at University of Toronto and has a laboratory based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto, said GLP-1s have gone from scientists questioning why anyone would want to use an injectable sulfonylurea to a class of drugs that have numerous benefits, including: reductions in albuminuria, atherosclerosis, body weight, blood pressure, cell death, fibrosis, glucose, gut motility, inflammation, oxidative stress, platelet aggregation, postprandial lipemia and thrombosis
Dr Dandona said: Within three months, we were able to eliminate all of the mealtime insulin doses for all of the patients and within six months we were able to eliminate basal [background] insulin in 7 of the 10 patients